Wave Life Sciences Ltd. (WVE)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 663 |
| % of all portfolios: | 0.023% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 17.78% | 1,786,278 | 0.40 | |
| Q2 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.24% | 18,718 | 0.00 | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 8.99% | 759,725 | 0.09 | |
| Q3 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 0.04% | 2,459 | 0.00 | |
| Q1 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 7.06% | 500,886 | 0.06 | |
| Q4 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 9.07% | 707,555 | 0.12 | |
| Q1 2020 | |||||
| ≡ | Meridian Contrarian Fund | Sell 100.00% | 160,000 | 0.23 | |
| Q4 2019 | |||||
| ≡ | Meridian Contrarian Fund | Reduce 24.53% | 52,000 | 0.07 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.